22. The pharmaceutical composition of claim 20 or 21, wherein the therapeutic agents are selected from the group consisting of doxorubicin, an antagonist of fibroblast-growth factor (FGF), hepatocyte growth factor (HGF), tissue factor (TF), protein C, protein S, platelet-derived growth factor ...